Novartis India Ltd.

View in App
1010.95 -19.35 ▼-1.9%

19 April 2024, 04:01:00 PM
Volume: 19,495

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.novartis.in
Market Cap 2,496.12 Cr.
Enterprise Value(EV) 2,006.05 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 38.69 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 26.13 Trailing Twelve Months Ending 2023-12
Industry PE 40.73 Trailing Twelve Months Ending 2023-12
Book Value / Share 295.19 Trailing Twelve Months Ending 2023-12
Price to Book Value 3.42 Calculated using Price: 1,010.95
Dividend Yield 4.70 Period Ending 2023-03
No. of Shares Subscribed 2.47 Cr. 24,690,797 Shares
FaceValue 5
About Novartis India Ltd.
Novartis has been in India since 1947. The Group operates in India through four entities namely Novartis India Limited, listed on the Mumbai Stock Exchange, Novartis Healthcare Private Limited, Sandoz Private Limited and Chiron-Behring Vaccine Private Limited. In India Novartis have a presence in pharmaceuticals, generics (pharmaceutical products that are off patent), Vaccines, OTC (over-the-counter medicines), eyecare and Animal Health.

Novartis India Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Novartis India Ltd. Performance

View details >>
1 Day
-1.88%
1 Week
-3.18%
1 Month
+2.43%
3 Month
+15.91%
6 Month
+41.24%
1 Year
+72.38%
2 Year
+56.57%
5 Year
+46.12%
10 Year
+118.84%

Novartis India Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 8.06 18.01 5.38 9.4 6.89 1.36 2.91 -0.53 14.07
Return on Capital Employed (%) 9.52 24.77 8.75 19.72 11.7 4.73 6.67 0.14 15.96
Return on Assets (%) 3.89 11.38 3.27 3.75 2.51 0.62 1.22 -0.18 5.09

Novartis India Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 1,002 1,194 920 734 759 721 711 692 776 702
Non Curr. Liab. 697 26 828 898 891 99 1,131 984 1,008 14
Curr. Liab. 362 204 323 482 367 417 357 334 268 139
Minority Int.
Equity & Liab. 2,060 1,425 2,070 2,113 2,018 1,237 2,199 2,010 2,052 855
Non Curr. Assets 846 161 959 1,009 1,029 240 1,277 1,183 1,266 259
Curr. Assets 1,215 1,264 1,111 1,104 989 997 922 826 786 597
Misc. Exp. not W/O
Total Assets 2,060 1,425 2,070 2,113 2,018 1,237 2,199 2,010 2,052 855

Novartis India Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 873 690 656 564 491 438 381 400 379 330
Other Income 112 245 72 174 78 36 34 34 58 68
Total Income 985 934 728 738 569 475 416 433 437 398
Total Expenditure -881 -659 -632 -572 -479 -427 -356 -373 -314 -267
PBIDT 104 275 96 166 91 48 60 60 123 131
Interest 0 0 -1 -6 -2 -6 -8 -5 -2 -2
Depreciation -4 -3 -4 -3 -3 -13 -12 -10 -6 -5
Taxation -14 -73 -35 -79 -34 -19 -19 0 -12 -29
Exceptional Items -6 -50
PAT 79 198 57 78 52 10 21 -4 103 96
Adjusted EPS 25 62 20 32 21 4 8 -2 42 39

Novartis India Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -5 -60 57 -41 161 -194 -23 -69 39 45
Cash Fr. Inv. 22 719 -630 424 69 274 56 95 87 -153
Cash Fr. Finan. -38 -38 -39 -332 -268 -30 -41 -37 -36 -30
Net Change -20 622 -612 51 -38 50 -9 -11 90 -139
Cash & Cash Eqvt 15 637 25 76 38 88 79 68 158 19

Novartis India Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 70.68 70.68 70.68 70.68 70.68 70.68 70.68 70.68 70.68
Public 29.32 29.32 29.32 29.32 29.32 29.32 29.32 29.32 29.32
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Novartis India Ltd. Announcements

View details >>
Mon, 15 Apr 2024
Compliances - Reg. 40(10) - PCS Certificate For Transfer / Transmission / Transposition
Compliances - Reg. 40(10) - PCS Certificate for Transfer / Transmission / Transposition
Wed, 10 Apr 2024
Compliances - Compliance Certificate For The Period Ended March 31 2024
Certificate under Regulation 7(3) of SEBI (LODR) Regulations 2015
Mon, 08 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018

Novartis India Ltd. Technical Scans

View details >>
Fri, 19 Apr 2024
Closing Below Previous Low Closing Below Previous Low
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year
High Increase in 2 Years High Increase in 2 Years

Novartis India Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 365,310.75 1,525.00 +0.5%
Cipla Ltd. 108,622.88 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. 99,134.26 5,942.65 -0.3%
Divi's Laboratories Ltd. 97,408.39 3,673.85 -1.2%
Mankind Pharma Ltd. 93,565.44 2,362.00 -1.5%
Zydus Lifesciences Ltd. 92,794.90 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. 88,715.85 6,152.25 +1.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.02 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-12 29.29 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 18.96 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-12 70.43 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-12 54.18 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.20 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 112.40 6,152.25 +1.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.85 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-12 4.19 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.69 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-12 7.47 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-12 10.53 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.92 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.14 6,152.25 +1.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 0.02 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,152.25 +1.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,152.25 +1.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,152.25 +1.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,152.25 +1.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,152.25 +1.4%

Novartis India Ltd. FAQ's

What is Novartis share price?
Can I buy Novartis shares now?
What is the Dividend Yield of Novartis?
What is the Market Cap of Novartis?
What are the key metrics to analyse Novartis?
What is the 52 Week High and Low of Novartis?
What is the trend of Novartis share price?